Riskpilot← Back to searchSign inGet full accessMedenteq AB
ABActiveOrg 5568437007Drottninggatan 46Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20111 employees
Revenue 2025
SEK 2,6M
-12% vs 2024
EBITDA margin
18.1%
-23% vs 2024
Equity ratio
69.5%
Financial strength
Net profit 2025
SEK 334K
-22% vs 2024
| Revenue | SEK 2,6M | -12% |
| EBITDA | SEK 474K | -23% |
| Net profit | SEK 334K | -22% |
| Total assets | SEK 1,2M | +31% |
| Equity | SEK 862K | +63% |
| Employees | 1 | — |
Legal name
Medenteq AB
Org number
5568437007
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
1 mars 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhet är att bedriva import och försäljning av medicinsk och dentala förbrukningsmaterial samt utrustning. Tandteknik, förbrukningsmaterial samt utrustning inom tandteknik. Utbildning och konsultationsverksamhet inom odontologi och företagsekonomiska områden.
Address
Drottninggatan 46
Email
info@medenteq.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 210 | 2 983 | 3 600 | 2 990 | 2 618 |
| Staff expenses | — | −702 | −528 | −620 | −648 |
| EBITDA | 1 298 | 733 | 1 344 | 614 | 474 |
| Depreciation & amort. | −0 | −18 | −195 | −54 | −54 |
| EBIT | 1 298 | 715 | 1 148 | 561 | 420 |
| Net financials | — | −9 | −60 | −23 | 1 |
| Profit before tax | 1 298 | 705 | 1 088 | 537 | 421 |
| Tax | −267 | −147 | −225 | −111 | −87 |
| Net profit | 1 031 | 558 | 863 | 426 | 334 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 534 | 1 228 | 1 992 | 947 | 1 241 |
| Equity | 1 081 | 739 | 1 002 | 528 | 862 |
| Long-term debt | 0 | 100 | 602 | 0 | — |
| Short-term debt | 454 | 389 | 388 | 419 | 379 |
| Total debt | 454 | 489 | 989 | 419 | 379 |
EBITDA margin
18.1%
This company
15.8%
Market median
+15% vs market
20212025
Equity ratio
69.5%
This company
38.2%
Market median
+82% vs market
20212025
Return on equity
38.7%
This company
18.4%
Market median
+110% vs market
20212025
Net profit margin
12.8%
This company
8.1%
Market median
+58% vs market
20212025
Asset turnover
2.11×
This company
1.12×
Market median
+88% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CG Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medenteq AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Gustav Magnus Ölander | Deputy Chief Executive Officer | 0 companies |
| Klas Håkan Lindeborg | Chairman | 0 companies |
| Anna Emma Sofie Belfrage | Deputy Board Member | 0 companies |
| Hans Morgan Filip Svärd | Board of Directors | 0 companies |